基本信息
views: 227
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Ohyashiki focused on cytogenetics in hematologic malignancies and one of the members for International Prognostic Scoring System for myelodysplastic syndromes (in 1997), and he contributes clinical implication of genetic abnormalities in hematologic malignancies, especially in myelodysplastic syndromes and chronic myeloid leukemia. He also interested in molecular cytogenetics, including telomere/telomerase dysfunction in hematologic malignancies.
Research Interests
Papers共 580 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Rurika Okuda,Yotaro Ochi,Ryunosuke Saiki,Nobuhiro Hiramoto,Masashi Sanada,Hiroshi Handa,Senji Kasahara, Shinya Sato,Nobuhiro Kanemura,Toshiyuki Kitano,Mizuki Watanabe, Wolfgang Kern,
CANCER SCIENCEno. 5 (2023): 229-229
Cancer scienceno. 8 (2023): 3461-3465
Cancer Researchno. 7_Supplement (2023): 6168-6168
CANCER RESEARCHno. 7 (2023)
Blood advances (2023)
M. Kjellander Kynning, Y. Nannya,G. Todisco,T. Yoshizato, B. Tesi,T. Mortera-Blanco, A.-C. Björklund,O. Brück,K. Ohyashiki, T. Ishikawa, Y. Ochi, T. Haferlach,
Leukemia Research (2023): 107256-107256
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn